THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Inclusion Criteria

• •Patient with severe aortic regurgitation (AR).
• •Patient at high risk for open surgical valve replacement
• •Patient symptomatic according to NYHA functional class II or higher
• •The study patient has been informed of the nature of the study, agrees to its provisions and has provided written informed consent as approved by the Institutional Review Board (IRB)/ Ethics Committee (EC) of the respective clinical site.